ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

September 1, 1978

Kidney, Bladder Cancer Causes, Treatment, Need More Research, NCI Advisors Find

July 26, 2002

In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives

August 29, 1975

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998